Oxidized low-density lipoproteins in cord blood from neonates with intra-uterine growth restriction

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 156, Issue 1, 2011, Pages 46-49

  Leduc, Line ^a   Delvin, Edgard ^a   Ouellet, Annie ^b   Garofalo, Carole ^a   Grenier, Emilie ^a   Morin, Lucie ^a   Dubé, Johanne ^a   Bouity Voubou, Maurice ^a   Moutquin, Jean Marie ^b   Fouron, Jean Claude ^a   Klam, Stephanie ^c   Levy, Emile ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Fetal programming; Inflammation; Intrauterine growth restriction; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERY RESISTANCE; ARTICLE; BIRTH WEIGHT; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; MODEL; NEWBORN; OXIDATIVE STRESS; PLACENTA INSUFFICIENCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TWIN PREGNANCY; UMBILICAL ARTERY; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD FLOW; UMBILICAL VEIN;

EID: 79955634811     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.01.007     Document Type: Article

References (31)

1. Miller J, Turan S, Baschat AA. Fetal growth restriction. Semin Perinatol 2008;32(4):80-274.
2. Petersen SG, Wong SF, Urs P, Gray PH, Gardiner GJ, et al. Early onset, severe fetal growth restriction with absent or reversed end-diastolic flow velocity waveform in the umbilical artery: perinatal and long-term outcomes. Aust N Z J Obstet Gynaecol 2009;49(1):45-51.
3. Barker DJ. The developmental origins of chronic adult disease. Acta Paediatr Suppl 2004;93(446):26-33. (Pubitemid 39664526)
4. Halvorsen CP, Andolf E, Hu J, Pilo C, Windbladh B, Norman M, et al. Discordant twin growth in utero and differences in blood pressure and endothelial function at 8 years of age. J Intern Med 2006;259(2):63-155.
5. Pesonen E, Johnsson J, Berg A. Intimal thickness of the coronary arteries in low-birthweight infants. Acta Paediatr 2006;95(10):8-1234.
6. Pladys P, Sinnlaub F, Brault S, et al. Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low-protein diet in utero.AmJ Physiol Regul Integr Comp Physiol 2005;289(6):R1580-8.
7. Arbuckle TE, Wilkins R, Sherman GJ. Birth weight percentiles by gestational age in Canada. Obstet Gynecol 1993;81(1):39-48. (Pubitemid 23041700)
8. Leduc L, Takser L, Rinfret D. Persistance of adverse obstetric and neonatal outcomes in monochorionic twins after exclusion of disorders unique to monochorionic placentation. Am J Obstet Gynecol 2005;193(5):5-1670.
9. Quintero RA, Morales WJ, Allen MH, Bormick PW, Johnson PK, kruger M, et al. Staging of twin - twin transfusion syndrome. J Perinatol 1999;19(8 Pt 1):5-550.
10. Bensouda B, Fouron JC, Raboisson MJ, Lachance C, Leduc L. Relevance of measuring diastolic time intervals in the ductus venosus during the early stages of twin - twin transfusion syndrome. Ultrasound Obstet Gynecol 2007;30(7):7-983.
11. Raboisson MJ, Fouron JC, Lamoureux J, et al. Early intertwin differences in myocardial performance during the twin-to-twin transfusion syndrome. Circulation 2004;110(19):8-3043.
12. Bernotti S, Seidman E, Sinnett D, et al. Inflammatory reaction without endogenous antioxidant response in Caco-2 cells exposed to iron/ascorbate- mediated lipid peroxidation. Am J Physiol Gastrointest Liver Physiol 2003;285(5):G898-906.
13. Kramer MS. The epidemiology of adverse pregnancy outcomes: an overview. J Nutr 2003;133(5 Suppl. 2):1592S-6.
14. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20(5):27-707.
15. Hracsko Z, Orvos H, Novak Z, Pal A, Varga IS. Evaluation of oxidative stress markers in neonates with intra-uterine growth retardation. Redox Rep 2008;13(1):6-11.
16. Gupta P, Narang M, Banerjee BD, Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatr 2004;4:14.
17. Boutsikou T, Mastorakos G, Kyriakakou M, et al. Circulating levels of inflammatory markers in intrauterine growth restriction. Mediators Inflamm 2010;2010:790605.
18. Kinalski M, Sledziewski A, Telejko B, et al. Lipid peroxidation, antioxidant defence and acid-base status in cord blood at birth: the influence of diabetes. Horm Metab Res 2001;33(4):31-227.
19. Anastasakis E, Papantoniou N, Daskalakis G, Mesogitis S, Antsaklis A, et al. Screening for pre-eclampsia by oxidative stress markers and uteroplacental blood flow. J Obstet Gynaecol 2008;28(3):9-285.
20. LaMarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep 2007;9(6):5-480.
21. Sitras V, Paulssen RH, Gronaas H, et al. Differential placental gene expression in severe preeclampsia. Placenta 2009;30(5):33-424.
22. Gu Y, Lewis DF, Deere K, Groone LJ, Wang Y, et al. Elevatedmaternal IL-16 levels, enhanced IL-16 expressions in endotheliumand leukocytes, and increased IL-16 production by placental trophoblasts in women with preeclampsia. J Immunol 2008;181(6):22-4418.
23. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009;30(Suppl. A):S38-42.
24. Walsh SW, Wang Y. Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 1993;169(6):6-1462.
25. Walsh SW,Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 1995;80(6):93-1888.
26. Biri A, Bozkurt N, Turp A, Kavutcu M, Himmetoglu O, Durak I. Role of oxidative stress in intrauterine growth restriction. Gynecol Obstet Invest 2007;64(4):92-187.
27. Takagi Y, Nikaido T, Toki T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004;444(1):49-55. (Pubitemid 38200090)
28. Hnat MD, Meadows JW, Brookman DE, Pitzer B, Lyall F, Myatt L. Heat shock protein-70 and 4-hydroxy-2-nonenal adducts in human placental villous tissue of normotensive, preeclamptic and intrauterine growth restricted pregnancies. Am J Obstet Gynecol 2005;193(3 Pt 1):40-836.
29. Liu Y, Li N, You L, Liu X, Li H, Wang X. HSP70 is associated with endothelial activation in placental vascular diseases. Mol Med 2008;14(9-10): 6-561.
30. Molvarec A, Rigo Jr J, Lazar L, et al. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 2009;14(2):9-151.
31. Rosta K, Molvarec A, Enzsoly A, et al. Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2009;142(2):8-134.